Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000664644 | SCV000788643 | pathogenic | Autosomal recessive nonsyndromic hearing loss 2; Usher syndrome type 1 | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861737 | SCV002229106 | pathogenic | not provided | 2024-06-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln821*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 12112664). ClinVar contains an entry for this variant (Variation ID: 550026). For these reasons, this variant has been classified as Pathogenic. |